BDMDWBaird Medical Investment Holdings Ltdvs its industry peers
A metric-by-metric comparison of Baird Medical Investment Holdings Ltd against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDMDW본 종목 | $5M#1 | — | 0.2x#1 | 0.2x#1 | -39.2%#5 | -319.0%#8 | -113.7%#5 | -87.0%#5 | -64.2%#5 | 1#2 | — | — |
| ALRTF | — | — | — | — | 978.8%#1 | -38.9%#7 | 16719.9%#1 | — | — | — | — | — |
| AURX | — | — | — | — | 142.7%#2 | -8.1%#3 | -76.0%#4 | — | — | 5#1 | — | — |
| BVS | — | — | — | — | -0.9%#4 | 162.9%#1 | 9.5%#2 | 12.0%#1 | 12.7%#1 | — | — | — |
| DRTS | — | — | — | — | — | -34.3%#5 | — | -55.3%#3 | -60.3%#3 | — | — | — |
| DRTSW | — | — | — | — | — | -34.3%#5 | — | -55.3%#3 | -60.3%#3 | — | — | — |
| EBRCZ | — | — | — | — | — | -19.5%#4 | -2850.2%#6 | -511.2%#6 | -102.9%#6 | — | — | — |
| ECIA | — | — | — | — | -0.5%#3 | 68.2%#2 | -2.6%#3 | -11.8%#2 | -7.9%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-08-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice